American Academy of Optometry (AAO) 2022
Evaluation of Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration: Analysis of the American Academy of Ophthalmology (AAO) IRIS® Registry
Treatment of Geographic Atrophy Secondary to AMD With Pegcetacoplan: Two-Year Outcomes From the Randomized Phase 3 OAKS and DERBY Trials
The Role of AI-Guided OCT Imaging in Geographic Atrophy
Efficacy of Intravitreal Pegcetacoplan in GA: 24-Month Results from the Phase 3 OAKS and DERBY Trials
Safety of Intravitreal Pegcetacoplan in GA: 24-Month Results From the Phase 3 OAKS and DERBY Trials
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.